EPITHELIAL HEPATOBLASTOMA IN A MALE INFANT WITH BECKWITH-WIEDEMANN SYNDROME: A CHALLENGING CASE REPORT

Authors

  • Lazo Jovcheski PHI University Clinic for Pediatric Surgery, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
  • Risto Simeonov PHI Clinical Hospital Acibadem Sistina, Department of Pediatric Surgery Skopje, Republic of North Macedonia Faculty of Medical Sciences, Goce Delcev University in Stip, Republic of North Macedonia
  • Zlatko Aleksovski PHI Clinical Hospital Acibadem Sistina, Department of Pediatric Surgery Skopje, Republic of North Macedonia
  • Martin Angjelov PHI Clinical Hospital Acibadem Sistina, Department of Pediatric Surgery Skopje, Republic of North Macedonia https://orcid.org/0000-0001-6177-1800 (unauthenticated)
  • Kamelija Simeonova PHI Clinical Hospital Acibadem Sistina, Department of Child and Adolescent Psychiatry Skopje, Republic of North Macedonia , PHI Clinical Hospital Acibadem Sistina, Department of Child and Adolescent Psychiatry Skopje, Republic of North Macedonia
  • Natali Jordanovska PZU “Atelas“, Centar za Bolka, Skopje, Republic of North Macedonia
  • Sandra Petkovska PHI Public Health Center Skopje, Republic of North Macedonia

DOI:

https://doi.org/10.53582/ve2gtt91

Keywords:

epithelial hepatoblastoma, embryonic pattern, male infant, Beckwith-Wiedemann syndrome, rare disease, SIOPEL, management

Abstract

Hepatoblastoma (HB) is among the most common pediatric primary liver tumor and constitutes almost 90% of tumors in children, aged 5 years, or younger. Hepatoblastomas are classified based on histological subtypes, which describe the types of cells and tissues present in the tumor. The primary classification divides them into epithelial and mixed epithelial and mesenchymal types. A two-month-old male infant was admitted at the Department of Pediatric Surgery-Clinical Hospital Acibadem Sistina, via referral from a pediatrician, with chief medical complaints of macroglossia, left-sided longitudinal hemi-hypertrophy and facial dysmorphic stigmatic features, for further clinical evaluation. After the initial physical examination, clinical investigations were obtained by protocol. Laboratory results showed elevated levels of lymphocytes, thrombocytes, RDW-SV, and hyperglycemia as well. The levels of alpha-fetoprotein (AFP) were >1000.0 (0-28 kiU/L). Imaging CT scan showed two tumefactions located between the 5th and 6/7th liver segments, clearly demarcated with dimensions of 57 mm (larger lesion) and 33 mm (smaller lesion), while the other intra-abdominal organs appeared normal. An urgent indication for surgical treatment was established, and a right-sided laparotomy was made. Intraoperative findings were two large liver masses located in the right lobe. Cholecystectomy and right partial hepatectomy were performed.  Histopathological analysis revealed epithelial hepatoblastoma, embryonal subtype. Histopathology was performed using the PRETEXT (Pretreatment Extent) staging system developed by the International Society of Pediatric Oncology (SIOPEL). After the procedure, chemotherapy was initiated according to the standard protocol.

References

1. Trobaugh-Lotrario AD, Venkatramani R, Feusner JH. Hepatoblastoma in children with Beckwith-Wiedemann syndrome: does it warrant different treatment? J Pediatr Hematol Oncol 2014; 36(5): 369-373. doi: 10.1097/MPH.0000000000000129.

2. Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, et al. Guidelines for surgical treatment of hepatoblastoma in the modern era: recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 2005; 41(7): 1031-1036. doi: 10.1016/j.ejca. 2005.02.004.

3. Klein SD, DeMarchis M, Linn RL, MacFarland SP, Kalish JM. Occurrence of hepatoblastomas in patients with Beckwith-Wiedemann spectrum (BWSp). Cancers (Basel) 2023; 15(9): 2548. doi: 10.3390/cancers15092548.

4. Brioude F, Kalish JM, Mussa A, Foster AC, Bliek J, Ferrero GB, et al. Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol 2018; 14(4): 229-249. doi: 10.1038/nrendo.2017.166.

5. Kalish JM, Becktell KD, Bougeard G, Brodeur GM, Diller LR, Doria AS, et al. Update on surveillance for Wilms tumor and hepatoblastoma in Beckwith-Wiedemann syndrome and other predisposition syndromes. Clin Cancer Res 2024; 30(23): 5260-5269. doi: 10.1158/1078-0432.CCR-24-2100.

6. Pilet J, Hirsch TZ, Gupta B, Roehrig A, Morcrette G, Pire A, et al. Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma. Nat Commun 2023; 14(1): 7122. doi: 10.1038/s41467-023-42418-9.

7. Sumazin P, Chen Y, Treviño LR, Sarabia SF, Hampton OA, Patel K, et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 2017; 65(1): 104-121. doi: 10.1002/hep.28888.

8. Kalish JM, Doros L, Helman LJ, Hennekam RC, Kuiper RP, Maas SM, et al. Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and hepatoblastoma. Clin Cancer Res 2017; 23(13): e115-e122. doi: 10.1158/1078-0432.CCR-17-0710.

Downloads

Published

2026-06-18

Issue

Section

Case Reports